Table 1. Characteristics of transplant recipients at baseline.
| Characteristics | Total (n=140) | fDGF (n=37) | IGF (n=103) | P value |
|---|---|---|---|---|
| Age (years) | 41.0 (32.0–50.0) | 40.0 (31.5–48.5) | 42.0 (32.0–50.0) | 0.607 |
| Sex male, n (%) | 85 (60.7) | 18 (48.6) | 67 (65.0) | 0.080 |
| BMI (kg/m2) | 21.35 (19.24–23.91) | 22.86 (19.29–25.40) | 21.88 (19.89–25.31) | 0.978 |
| Pre-Scr (μmol/L) | 880.20 (690–1172.25) | 904.00 (739.15–1,165.00) | 874.00 (685.00–1,175.00) | 0.789 |
| Pre-eGFR (mL/min/1.73 m2) preoperative | 5.207 (4.025–7.154) | 4.797 (3.737–6.885) | 5.349 (4.112–7.272) | 0.345 |
| Hb (g/L) | 108.00 (96.50–120.00) | 113.00 (99.50–126.00) | 110.00 (99.00–125.00) | 0.355 |
| Alb (g/L) | 46.00 (42.00–48.80) | 44.75 (41.73–48.28) | 47.90 (44.80–51.00) | 0.077 |
| TC (mmol/L) | 1.54 (1.09–3.06) | 1.54 (1.00–3.21) | 1.62 (1.30–2.93) | 0.494 |
| TG (mmol/L) | 4.55 (3.55–5.28) | 4.62 (3.95–5.08) | 4.70 (4.00–5.48) | 0.637 |
| HDL (mmol/L) | 1.13 (0.87–1.55) | 1.07 (0.90–1.78) | 1.05 (0.82–1.31) | 0.485 |
| LDL (mmol/L) | 2.37 (1.93–3.14) | 2.35 (1.93–2.75) | 2.47 (2.02–3.22) | 0.332 |
| Ca2+ (mmol/L) | 2.36 (2.23–2.51) | 2.36 (2.26–2.50) | 2.36 (2.22–2.51) | 0.650 |
| P (mmol/L) | 1.79 (1.31–2.27) | 2.09 (1.41–2.55) | 1.74 (1.27–2.35) | 0.779 |
| iPTH (pg/L) | 206.45 (90.10–412.43) | 165.75 (110.88–320.83) | 228.70 (105.10–552.00) | 0.716 |
| Duration time of dialysis (m) | 10.00 (3.00–24.00) | 12.00 (5.50–31.00) | 10.00 (2.00–24.00) | 0.155 |
| Mode of dialysis, n (%) | 0.069 | |||
| HD | 73 (52.1) | 19 (51.4) | 57 (52.4) | |
| PD | 42 (30.0) | 16 (43.2) | 29 (28.2) | |
| Hypertension, n (%) | 106 (75.7) | 32 (86.5) | 74 (71.8) | 0.075 |
| Diabetes, n (%) | 7 (5.0) | 1 (2.7) | 6 (5.8) | 0.455 |
| Neutrophil (%) | 68.80 (63.65–73.40) | 69.20 (67.00–74.30) | 67.60 (63.40–73.50) | 0.121 |
| Lymphocyte (%) | 21.40 (17.85–26.05) | 20.50 (15.00–24.50) | 23.00 (18.20–27.10) | 0.079 |
| WBC (×109/L) | 7.29 (6.09–8.24) | 7.56 (5.91–8.76) | 7.18 (6.00–8.61) | 0.972 |
| K (mmol/L) | 4.10 (3.55–4.70) | 4.10 (3.40–4.70) | 4.10 (3.60–4.60) | 0.397 |
| Na+ (mmol/L) | 139.00 (137.00–141.00) | 139.00 (137.00–140.00) | 139.00 (137.00–141.00) | 0.944 |
| HCO3− (mmol/L) | 23.25 (21.80–25.63) | 24.50 (21.80–28.20) | 23.20 (21.80–25.60) | 0.290 |
| Globulin (g/L) | 29.322±5.673 | 28.017±4.705 | 29.767±5.927 | 0.152 |
| Prealbumin (mg/L) | 408.475±84.416 | 399.207±96.139 | 411.877±80.087 | 0.492 |
| ALT (U/L) | 13.10 (11.00–19.35) | 13.00 (11.00–19.00) | 14.00 (10.00–20.00) | 0.982 |
| AST (U/L) | 14.00 (12.00–17.70) | 13.90 (11.00–18.00) | 14.90 (11.95–18.05) | 0.716 |
| γ-GT (U/L) | 20.00 (14.00–31.50) | 19.00 (13.00–28.00) | 20.00 (13.70–31.40) | 0.637 |
| HLA mismatches (ABDR), n (%) | 0.357 | |||
| 0 | 135 (96.4) | 35 (94.6) | 100 (97.1) | |
| 1–2 | 4 (2.9) | 1 (2.7) | 3 (2.9) | |
| 3 | 1 (0.7) | 1 (2.7) | 0 (0.0) | |
| Hot ischemia time (min) | 5.00 (4.73–5.70) | 4.90 (4.70–5.20) | 5.10 (4.80–5.60) | 0.057 |
| Cold ischemia time (hours) | 4.60 (2.50–5.10) | 4.30 (2.25–4.95) | 4.70 (3.40–5.10) | 0.067 |
Data that conform to a normal distribution are represented by the mean ± standard deviation (SD), and non-normally distributed data are represented by the median (interquartile range). Frequency of occurrence of the event is expressed as the frequency (percentage). fDGF, functional delayed graft function; IGF, immediate graft function; BMI, body mass index; pre-Scr, pre-operative serum creatinine; pre-eGFR, pre-operative estimated glomerular filtration rate; Hb, hemoglobin; Alb, serum albumin; TC, serum total cholesterol; TG, serum triglyceride; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; Ca2+, serum total calcium; P, serum phosphorus; iPTH, immunoreactive serum parathyroid hormone; HD, hemodialysis; PD, peritoneal dialysis; WBC, white blood cells; K, serum potassium; Na+, serum sodium; HCO3−, serum bicarbonate; ALT, glutamate pyruvic transaminase; AST, aspartate aminotransferase; γ-GT, γ-glutamyl transpeptidase; ALP, alkaline phosphatase; HLA, human leukocyte antigen.